Optimal nonvitamin K antagonist oral anticoagulant therapy in a warfarin-sensitive patient after left atrial appendage closure: A case report

RATIONALE: Developing an optimal medication strategy poses a challenging task in fragile patients after left atrial appendage closure (LAAC). We report an optimal nonvitamin K antagonist oral anticoagulant (NOAC) therapy in a warfarin-sensitive patient after LAAC. PATIENT CONCERNS: A 77-year-old non...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Long, Fang, Sha-Sha, Ge, Heng, Qiao, Zhi-Qing, Gu, Zhi-Chun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6392999/
https://www.ncbi.nlm.nih.gov/pubmed/29718897
http://dx.doi.org/10.1097/MD.0000000000010683

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6392999/
https://www.ncbi.nlm.nih.gov/pubmed/29718897
http://dx.doi.org/10.1097/MD.0000000000010683

Ejemplares similares